IP Library › Granted Patent US 10,245,305
Granted Patent B2
US 10,245,305 · App. 14/689,390 · Granted Apr 2, 2019

Botulinum toxin therapy for skin disorders

Inventor: Eric R. First (Morristown, NJ)
Assignee: Allergan, Inc.
A61K38/4893A61K9/0014A61K9/0019C12Y304/24069A61K8/64A61Q19/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,245,305
App. No.
14/689,390
Granted
Apr 2, 2019
Kind
B2
Abstract

Methods for treating skin disorders by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a skin disorder.

Claims (6)

1. A method for reducing the occurrence or alleviating a melanin related affliction in a patient in need thereof, the method comprising the step of locally administering a therapeutically effective amount of a botulinum toxin to an area affected by the melanin related affliction, thereby reducing the occurrence or alleviating the melanin related affliction, wherein the melanin related affliction is selected from the group consisting of dermatofibromas, freckles and atypical moles (dysplastic nevi).

2. The method of claim 1 , wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G.

3. The method of claim 1 , wherein the botulinum toxin is a native botulinum toxin.

4. The method of claim 1 , wherein the botulinum toxin is a modified botulinum toxin.

5. The method of claim 1 , wherein the administering is via a transdermal route, subdermal route, intradermal route, or combinations thereof.

6. The method of claim 1 , wherein the therapeutically effective amount is an amount effective to cause a skin pigmentation change.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2015
From: FIRST, ERIC
To: ALLERGAN, INC.
Reel/Frame 035434/0835 →
Continuity (5)
Continuation 14493756 · Sep 23, 2014
Continuation 13073741 · Mar 28, 2011
Continuation In Part 12762110 · Apr 16, 2010
Continuation 10731973 · Dec 9, 2003
Related Publication 20150216953A1 · Aug 6, 2015
Cited By (2)
US 12,280,096 US 12,599,625